These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 31682364)

  • 61. [Crispr-Cas9 Gene Editing Revolution and the Its Ethical and Legal Challenges].
    Bellver Capella V
    Cuad Bioet; 2016; 27(90):223-39. PubMed ID: 27637196
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Applications of CRISPR Technologies Across the Food Supply Chain.
    Brandt K; Barrangou R
    Annu Rev Food Sci Technol; 2019 Mar; 10():133-150. PubMed ID: 30908954
    [TBL] [Abstract][Full Text] [Related]  

  • 63. One Cut to Change Them All: CRISPR/Cas, a Groundbreaking Tool for Genome Editing in
    Hahn M; Scalliet G
    Phytopathology; 2021 Mar; 111(3):474-477. PubMed ID: 33021880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pre-existing technological core and roots for the CRISPR breakthrough.
    Magee CL; Kleyn PW; Monks BM; Betz U; Basnet S
    PLoS One; 2018; 13(9):e0198541. PubMed ID: 30231020
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Patent pools for CRISPR technology.
    Horn L
    Science; 2017 Mar; 355(6331):1274. PubMed ID: 28336631
    [No Abstract]   [Full Text] [Related]  

  • 68. Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology.
    Burgio G
    Genome Biol; 2018 Feb; 19(1):27. PubMed ID: 29490686
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Zinc Fingers, TALEs, and CRISPR Systems: A Comparison of Tools for Epigenome Editing.
    Waryah CB; Moses C; Arooj M; Blancafort P
    Methods Mol Biol; 2018; 1767():19-63. PubMed ID: 29524128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites.
    Cui Y; Yu L
    Parasitol Int; 2016 Dec; 65(6 Pt A):641-644. PubMed ID: 27586395
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Applications of CRISPR-Cas systems in neuroscience.
    Heidenreich M; Zhang F
    Nat Rev Neurosci; 2016 Jan; 17(1):36-44. PubMed ID: 26656253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Patent pools for CRISPR technology-Response.
    Contreras JL; Sherkow JS
    Science; 2017 Mar; 355(6331):1274-1275. PubMed ID: 28336632
    [No Abstract]   [Full Text] [Related]  

  • 74. Genome editing: CRISPR-Cas becoming more human.
    Baumann K
    Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
    [No Abstract]   [Full Text] [Related]  

  • 75. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
    Kim EJ; Kang KH; Ju JH
    Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Analysis of microsatellite instability in CRISPR/Cas9 editing mice.
    Huo X; Du Y; Lu J; Guo M; Li Z; Zhang S; Li X; Chen Z; Du X
    Mutat Res; 2017 Mar; 797-799():1-6. PubMed ID: 28284774
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
    Shen J; Zhou J; Chen GQ; Xiu ZL
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
    [No Abstract]   [Full Text] [Related]  

  • 78. CRISPR-Cas9 Targeting of PCSK9 in Human Hepatocytes In Vivo-Brief Report.
    Wang X; Raghavan A; Chen T; Qiao L; Zhang Y; Ding Q; Musunuru K
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):783-6. PubMed ID: 26941020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Delivery and Specificity of CRISPR-Cas9 Genome Editing Technologies for Human Gene Therapy.
    Gori JL; Hsu PD; Maeder ML; Shen S; Welstead GG; Bumcrot D
    Hum Gene Ther; 2015 Jul; 26(7):443-51. PubMed ID: 26068008
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The CRISPR Patent Ruling and Implications for Medicine.
    Paradise J
    JAMA; 2023 Feb; 329(6):461-462. PubMed ID: 36637817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.